| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |